ClinicalTrials.govpublic full text
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
relapsed acute myeloid leukemia, pembrolizumab, decitabine, aml (acute myelogenous leukemia), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845381
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.